| Name | Title | Contact Details |
|---|
Gateway Family House is a Cleveland, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
DRE Medical Inc is a Louisville, KY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Caregiver's Home Companion is a Southport, CT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Veterans Evaluation Services is a company that supports the U.S. Department of Veterans Affairs in providing veterans and transitioning service members with the benefits theyve earned through their service to the country. They provide high quality, ti...
Orbus Therapeutics is dedicated to developing products that treat rare diseases for which there are few, if any, effective therapies. The company’s product candidate in development is eflornithine in an oral solution. Eflornithine is a novel cytostatic agent, which Orbus Therapeutics is developing for the treatment of patients with anaplastic glioma (AG), or Grade 3 glioma, a rare form of central nervous system cancer. Eflornithine irreversibly inhibits ornithine decarboxylase (ODC), a key enzyme in mammalian polyamine biosynthesis that is up-regulated in various types of cancer. Orbus Therapeutics intends to develop and commercialize eflornithine in North America.